drugset / Trial / NCT01226511
A Study in Pediatric Participants With Generalized Anxiety Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to find out if duloxetine \[30-120 milligrams (mg)\] given once a day by mouth for 10 weeks to children and adolescents, is better than placebo when treating Generalized Anxiety Disorder (GAD).
Timeline
- Start
- 2011-06
- Primary completion
- 2013-02
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 30 mg | Oral |
| Subject | Duloxetine | Small molecule | 120 mg | Oral |